Spots Global Cancer Trial Database for cinv
Every month we try and update this database with for cinv cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Fosaprepitant in Patients Receiving Ifosfamide-based Regimen | NCT01490060 | Sarcoma Chemotherapy-in... Effects of Chem... Adverse Effects... | Fosaprepitant Dexamethasone 5HT3 receptor a... Ifosfamide-base... Doxorubicin Mesna Ifosfamide Vincristine | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer | NCT05244577 | Olanzapine CINV Testicular Canc... Cisplatin | Olanzapine Tabl... Placebo | 16 Years - | Sun Yat-sen University | |
| Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer | NCT05841849 | Breast Cancer Chemotherapy-in... | Aprepitant Palonosetron Fosaprepitant | 18 Years - 70 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Laser Acupuncture Against Nausea in Children | NCT00528554 | Nausea Vomiting Cancer | laser acupunctu... placebo laser a... | - 17 Years | University Children Hospital Homburg | |
| Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy | NCT00169572 | Nausea and Vomi... Chemotherapy-In... | Aprepitant Ondansetron GW679769 Dexamethasone | 18 Years - | GlaxoSmithKline | |
| Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years | NCT01596426 | Chemotherapy In... | Sancuso IV granisetron | 2 Years - 5 Years | Kyowa Kirin Pharmaceutical Development Ltd | |
| Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin | NCT00430313 | Liver Cancer Liver Metastasi... | Electro-Stimula... Electro-Stimula... | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide | NCT01450826 | Nausea Vomiting Glioma | aprepitant ondansetron | 18 Years - | Duke University | |
| Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years | NCT01596426 | Chemotherapy In... | Sancuso IV granisetron | 2 Years - 5 Years | Kyowa Kirin Pharmaceutical Development Ltd | |
| Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years | NCT01596413 | Chemotherapy In... | Sancuso IV granisetron | 6 Years - 12 Years | Kyowa Kirin Pharmaceutical Development Ltd | |
| Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting | NCT01031498 | Acute Myelogeno... Chemotherapy-in... | Ondansetron Palonosetron | 18 Years - | M.D. Anderson Cancer Center | |
| Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer | NCT05841849 | Breast Cancer Chemotherapy-in... | Aprepitant Palonosetron Fosaprepitant | 18 Years - 70 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy | NCT00169572 | Nausea and Vomi... Chemotherapy-In... | Aprepitant Ondansetron GW679769 Dexamethasone | 18 Years - | GlaxoSmithKline | |
| Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin | NCT00430313 | Liver Cancer Liver Metastasi... | Electro-Stimula... Electro-Stimula... | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide | NCT01450826 | Nausea Vomiting Glioma | aprepitant ondansetron | 18 Years - | Duke University | |
| Efficacy of Ear Acupuncture in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients | NCT05851625 | Pediatric Cance... Chemotherapy-in... Chemotherapy Ef... | Press needle ac... Plesterin | 6 Years - 18 Years | Indonesia University | |
| A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy | NCT00431236 | Nausea and Vomi... | Oral Casopitant... IV Casopitant (... IV ondansetron ... Oral dexamethas... | 18 Years - | GlaxoSmithKline | |
| Multi-day Doses in Prevention of Nausea and Emesis | NCT00600353 | Myeloma, Plasma... Lymphoma, Malig... | Palonosetron Aprepitant Dexamethasone | 18 Years - | University of Kansas Medical Center | |
| Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years | NCT01596400 | Chemotherapy In... | granisetron tra... Granisetron IV | 13 Years - 17 Years | Kyowa Kirin Pharmaceutical Development Ltd | |
| A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy | NCT00431236 | Nausea and Vomi... | Oral Casopitant... IV Casopitant (... IV ondansetron ... Oral dexamethas... | 18 Years - | GlaxoSmithKline |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
